ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies, and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution. ICON currently has around 8,600 employees, operating from 84 locations in 40 countries.
Website: www.iconplc.com/

PPD
PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical , biotechnology , medical device , academic and government organizations. With offices in 45 countries and more than 11,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com .

Quintiles
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of more than 25,000 professionals in 60 countries has an eye on the future while delivering results today with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies develop and commercialize products to improve and lengthen patients’ lives while demonstrating value to stakeholders. visit www.quintiles.com. for more information and www.quintiles.com/news for additional company news

To discuss remaining sponsorship opportunities for 2013, please contact us:

Matt Dias
Tel: +44 (0)20 7017 4188
Email: Matt.dias@informa.com